The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting

NCT00689013 | Completed

• 1 other identifier: 8750
• Study Type: interventional
• Target: 205
• Locations: 1 country
• Sites: 3

Brief Summary

The purpose of this study is to determine whether pharmacist-driven patient interventions can have an effect on the number of herpes zoster (Zostavax) vaccinations given in a community pharmacy setting.

Conditions

Herpes Zoster

Keywords

Herpes Zoster; Prevention & control; Pharmacists; Pharmacy; Pharmacies; Aged; Immunization; Vaccination

Outcome Measures

Primary Outcomes (1)

• To assess the effect of a pharmacist-driven immunization campaign on the rate of Zostavax immunizations in three separate community pharmacy settings

  2 months

Secondary Outcomes (2)

• To evaluate the relative efficacy of specific interventions on the rate of herpes zoster vaccinations

  2 months

• To evaluate the perception of patients receiving the herpes zoster vaccination as to the role of pharmacists as immunizers

  2 months

Study Arms (2)

1

NO INTERVENTION

Patients voluntarily presenting to community pharmacies who request receipt of the herpes zoster vaccine during the first month of observation. These patients have not been exposed to pharmacist-driven interventions utilized in this study. This group serves as the control group.

2

EXPERIMENTAL

Patients voluntarily presenting to community pharmacies who request receipt of the herpes zoster vaccine during the second month of observation. These patients may or may not have been exposed to pharmacist-driven interventions utilized in this study. This group serves as the study/intervention group.

Other: Personalized letter; Other: Flyer advertisement; Other: Newspaper press release

Interventions

Personalized letter OTHER

On Day 1 of the 2nd month, a personalized letter (addressing specific patient) was mailed to current pharmacy patients with indications for the Zostavax vaccine. Current patients were defined as those receiving at least one prescription medication from the pharmacy within 6 months. The personalized letter provided detailed information about herpes zoster infection, the vaccine for herpes zoster prevention, indications for vaccine receipt and contraindications for vaccine receipt.

Also known as: Letter

2

Flyer advertisement OTHER

Beginning on Day 1 of the 2nd month, flyer advertisements were distributed with all pharmacy sales. Flyer advertisements provided detailed information about herpes zoster infection, the vaccine for herpes zoster prevention, indications for vaccine receipt and contraindications for vaccine receipt.

Also known as: Flyer

2

Newspaper press release OTHER

During the first week of the 2nd month, local newspapers published press releases. The press release provided detailed information about herpes zoster infection, the vaccine for herpes zoster prevention, indications for vaccine receipt and contraindications for vaccine receipt.

Also known as: Newspaper Ad

2

Eligibility Criteria

• Age: 60 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• men and women aged 60 or older without contraindications for the herpes zoster vaccination

You may not qualify if:

• Patients aged \< 60 years
• Anyone who has previously received the herpes zoster vaccine
• Anyone with an allergy to neomycin, gelatin or any other component of the vaccine
• Anyone receiving a live vaccine within 4 weeks
• Anyone with a compromised or weakened immune systems such as those receiving radiation, corticosteroids, or those with HIV/AIDS, cancer in the lymph, bone or blood systems
• Pregnant women or those in close contact with a pregnant woman

Sponsors & Collaborators

• University of Tennessee: lead
• Merck Sharp & Dohme LLC: collaborator
• American Pharmacists Association: collaborator

Study Sites (3)

Wilson Pharmacy

Johnson City, Tennessee, 37602, United States

Location

Marcrom's Pharmacy

Manchester, Tennessee, 37355, United States

Location

Reeves-Sain Drug Store

Murfreesboro, Tennessee, 37129, United States

Location

MeSH Terms

Conditions

Herpes Zoster

Interventions

College Fraternities and Sororities

Condition Hierarchy (Ancestors)

Varicella Zoster Virus Infection; Herpesviridae Infections; DNA Virus Infections; Virus Diseases; Infections

Intervention Hierarchy (Ancestors)

Organizations; Health Care Economics and Organizations

Study Officials

• Lindsay J Ford, Pharm.D.

  University of Tennessee Community Pharmacy Residency Program

  PRINCIPAL INVESTIGATOR

• Sarah K Frank, Pharm.D.

  University of Tennessee Community Pharmacy Residency Program

  STUDY CHAIR

• Nina H Jaber, Pharm.D.

  University of Tennessee Community Pharmacy Residency Program

  STUDY CHAIR

• Stephan L Foster, Pharm.D.

  University of Tennessee Community Pharmacy Residency Program

  STUDY DIRECTOR

• Richard Randolph, Pharm.D.

  University of Tennessee Community Pharmacy Residency Program

  STUDY CHAIR

• Steve Lane, Pharm.D.

  University of Tennessee Community Pharmacy Residency Program

  STUDY CHAIR

• Cindy T Smith, Pharm.D.

  University of Tennessee Community Pharmacy Residency Program

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: FACTORIAL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: May 21, 2008
• First Posted: June 3, 2008
• Study Start: February 1, 2008
• Primary Completion: March 1, 2008
• Study Completion: March 1, 2008
• Last Updated: April 23, 2009

Record last verified: 2009-04

Locations

US (3)